Buffett’s Berkshire pares drug holdings, sheds Axalta, Biogen
Warren Buffett’s Berkshire Hathaway Inc (BRKa.N) said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co (MRK.N) spinoff, Organon & Co (OGN.N).
Aon, Willis halt $30 bln merger over monopoly concerns, delay
Aon Plc (AON.N) and Willis Towers Watson Plc on Monday called off a $30 billion merger that would have created the world’s largest insurance broker, saying U.S. regulators’ objections created unacceptable delay and uncertainty.
